-The Economic Times NEW DELHI: An ailing economy and an emerging destination for medical tourism, India has just made it easier for its bureaucrats and their immediate family members to fly abroad for treatment at the government's expense. The Centre has decided to reimburse the total cost of treatment abroad as well as fund the return airfare for IAS, IPS and IFS officers, changing the 30-year-old rules at a time the government...
More »SEARCH RESULT
Total Matching Records found : 334
Non communicable diseases causing more premature deaths in India now -Jyotsna Singh
-Down to Earth World Bank report says heart diseases have replaced TB and sepsis as two of the five leading causes of deaths between 1990 and 2010 Reasons for premature deaths in India have seen a significant shift over the past two decades. In 1990, the top five reasons were communicable diseases. In 2010, two of the top five reasons for premature deaths are non-communicable diseases (NCDs). Diet-related risks are the leading...
More »Indians have 30% weaker lungs than Europeans: Study -Durgesh Nandan Jha
-The Times of India NEW DELHI: In another proof that worsening air quality in Indian cities is affecting people's health, a study has found that Indians have 30% lower lung function as compared to Europeans. Things could get worse if immediate steps are not taken to curb vehicular emission, doctors warned. The study was conducted on 10,000 healthy, non-smoking individuals in Jaipur, Pune, Hyderabad, Kolkata and Kashmir. "We measured the Peak Expiratory...
More »Epidemic of Vitamin D shortage puts Indians at high blood pressure risk -Malathy Iyer
-The Times of India MUMBAI: Runny noses and stomach flu aren't the only ills associated with overcast skies. The absence of sunlight hits production of Vitamin D in the body, adversely affecting blood pressure. A recent study in London by an Indian-born researcher has proved beyond doubt that the lower the vitamin level, the higher the BP. Vitamin D is synthesized when the sun's ultraviolet rays fall on the skin. But the...
More »Price control, IP Act & regulatory framework: Revisiting some imp issues about Indian pharma-Ramesh Adige
-The Economic Times Over a year ago, I had written a piece, Quo Vadis, Indian Pharma? (ET, May 11, 2012), in this column. Some key issues were highlighted in the article. Perhaps it is time to revisit the subject and bring out some current issues. Price control: Hurray, the department of pharmaceuticals has come out with a new non-intrusive price control methodology, moving from the cost-based model to the average market price...
More »
